Hiroki Yoshimatsu
Pfizer R&D Japan
Tokyo, Japan
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.
Journal: The journal of headache and pain
Published: December 17, 2025
Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Journal: Headache
Published: September 21, 2025
Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Journal: Headache
Published: January 23, 2025
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.
Journal: Headache
Published: November 28, 2024
Pharmacokinetics, Safety, and Tolerability of Single-Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double-Blind, Phase 1 Studies.
Journal: Clinical pharmacology in drug development
Published: October 17, 2024
Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: June 21, 2024
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
Journal: International journal of hematology
Published: January 25, 2023
Clinical implication of children's depression rating scale-revised score: Linking the children's depression rating scale-revised score and clinical global impression using patients data from clinical trials.
Journal: Health science reports
Published: January 12, 2023
Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
Journal: International journal of hematology
Published: June 27, 2022
Item Response Analyses of the Children's Depression Rating Scale-Revised Using Data from Clinical Studies.
Journal: Journal of child and adolescent psychopharmacology
Published: May 11, 2022
Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.
Journal: Pain and therapy
Published: October 20, 2021
Last Updated: 09/26/2026